Gene_set	Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Amoebiasis	9/102	2.1294619160840012e-14	1.682274913706361e-12	0	0	91.59907834101382	2883.5684788493977	LAMA5;TGFB1;COL4A2;LAMB2;COL4A1;COL4A4;COL4A3;COL4A6;COL4A5
KEGG_2021_Human	Focal adhesion	10/201	2.1167874871983642e-13	8.361310574433538e-12	0	0	51.77748691099477	1511.058986793479	LAMA5;COL4A2;LAMB2;COL4A1;COL4A4;COL4A3;COL4A6;KDR;COL4A5;VEGFA
KEGG_2021_Human	ECM-receptor interaction	8/88	5.484097486292917e-13	1.444145671390468e-11	0	0	90.4090909090909	2552.4071841542436	LAMA5;COL4A2;LAMB2;COL4A1;COL4A4;COL4A3;COL4A6;COL4A5
KEGG_2021_Human	Small cell lung cancer	8/92	7.910615296124925e-13	1.5623465209846726e-11	0	0	86.08658008658008	2398.837044102355	LAMA5;COL4A2;LAMB2;COL4A1;COL4A4;COL4A3;COL4A6;COL4A5
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	8/100	1.569154573296129e-12	2.4792642258078835e-11	0	0	78.56916996047431	2135.5480772141473	TGFB1;COL4A2;COL4A1;COL4A4;COL4A3;COL4A6;COL4A5;VEGFA
KEGG_2021_Human	Relaxin signaling pathway	8/129	1.2492564782919032e-11	1.6448543630843388e-10	0	0	59.65138993238167	1497.6010828305214	TGFB1;COL4A2;COL4A1;COL4A4;COL4A3;COL4A6;COL4A5;VEGFA
KEGG_2021_Human	Human papillomavirus infection	10/331	3.015466896600074e-11	3.4031697833057975e-10	0	0	30.605919003115265	741.4186351774827	LAMA5;COL4A2;LAMB2;COL4A1;COL4A4;COL4A3;COL4A6;COL4A5;TCIRG1;VEGFA
KEGG_2021_Human	PI3K-Akt signaling pathway	10/354	5.831990783844669e-11	5.75909089904661e-10	0	0	28.526162790697676	672.2212400355796	LAMA5;COL4A2;LAMB2;COL4A1;COL4A4;COL4A3;COL4A6;KDR;COL4A5;VEGFA
KEGG_2021_Human	Pathways in cancer	11/531	1.4421154974147611e-10	1.2658569366196235e-09	0	0	21.65485829959514	490.6934544528378	LAMA5;TGFB1;COL4A2;LAMB2;COL4A1;COL4A4;COL4A3;COL4A6;COL4A5;VEGFA;NFE2L2
KEGG_2021_Human	Protein digestion and absorption	6/103	8.647767985562035e-09	6.831736708594009e-08	0	0	51.21907216494845	950.9314799243326	COL4A2;COL4A1;COL4A4;COL4A3;COL4A6;COL4A5
KEGG_2021_Human	Proteoglycans in cancer	4/205	0.00023835873976966456	0.001711849131073	0	0	15.13126674320704	126.22099785452004	TGFB1;KDR;MIR21;VEGFA
KEGG_2021_Human	Rheumatoid arthritis	3/93	0.0003607851781524913	0.0023751690895039	0	0	24.54320987654321	194.55961688941923	TGFB1;TCIRG1;VEGFA
KEGG_2021_Human	Renin-angiotensin system	2/23	0.0005396091866801571	0.0032791635190563	0	0	67.85374149659864	510.5767014966948	ACE;REN
KEGG_2021_Human	Toxoplasmosis	3/112	0.0006216351196870161	0.0035077981753767	0	0	20.245667686034658	149.47694839317748	LAMA5;TGFB1;LAMB2
KEGG_2021_Human	Fluid shear stress and atherosclerosis	3/139	0.0011624653844621	0.0061223176915006	0	0	16.204248366013072	109.49554471424038	KDR;VEGFA;NFE2L2
KEGG_2021_Human	Diabetic cardiomyopathy	3/203	0.0034181522884767	0.0163997203104523	0	0	10.983333333333333	62.37056229240534	TGFB1;ACE;REN
KEGG_2021_Human	VEGF signaling pathway	2/59	0.0035290537376922	0.0163997203104523	0	0	24.953634085213032	140.90632208004251	KDR;VEGFA
KEGG_2021_Human	Renin secretion	2/69	0.0047940362554891	0.0199330981149286	0	0	21.218550106609808	113.31517536894962	ACE;REN
KEGG_2021_Human	Renal cell carcinoma	2/69	0.0047940362554891	0.0199330981149286	0	0	21.218550106609808	113.31517536894962	TGFB1;VEGFA
KEGG_2021_Human	Pancreatic cancer	2/76	0.0057862287304151	0.0228556034851398	0	0	19.204633204633204	98.94754273926414	TGFB1;VEGFA
KEGG_2021_Human	Synaptic vesicle cycle	2/78	0.0060855510763654	0.0228932635729938	0	0	18.69736842105263	95.3909445901031	AP2B1;TCIRG1
KEGG_2021_Human	Hypertrophic cardiomyopathy	2/90	0.0080262538558438	0.0288215479368937	0	0	16.13798701298701	77.86639055063492	TGFB1;ACE
KEGG_2021_Human	MAPK signaling pathway	3/294	0.0095193878803135	0.0326970279367291	0	0	7.5139366170294	34.97305241395518	TGFB1;KDR;VEGFA
KEGG_2021_Human	Chagas disease	2/102	0.0102087472469366	0.0336037930211664	0	0	14.192857142857145	65.06730050963371	TGFB1;ACE
KEGG_2021_Human	Lysosome	2/128	0.0157259628055729	0.0496940424656104	0	0	11.249433106575964	46.71262132671351	TCIRG1;GLA
KEGG_2021_Human	Tight junction	2/169	0.0264467050992696	0.0773811001052704	0	0	8.470059880239521	30.76854025590145	MYH9;SYNPO
KEGG_2021_Human	Hepatocellular carcinoma	2/168	0.0261578070672306	0.0773811001052704	0	0	8.521514629948365	31.049055329541552	TGFB1;NFE2L2
KEGG_2021_Human	Tuberculosis	2/180	0.0297100575159264	0.083824805134221	0	0	7.942215088282504	27.926969897277015	TGFB1;TCIRG1
KEGG_2021_Human	Rap1 signaling pathway	2/210	0.0393705553215437	0.1046622506494829	0	0	6.7864010989010985	21.952223199246387	KDR;VEGFA
KEGG_2021_Human	Collecting duct acid secretion	1/27	0.0397451584744871	0.1046622506494829	0	0	26.450928381962864	85.31131290182489	TCIRG1
KEGG_2021_Human	Galactose metabolism	1/31	0.0455019066193127	0.1159564717072807	0	0	22.919540229885055	70.82140338003367	GLA
KEGG_2021_Human	Ras signaling pathway	2/232	0.0471136446414104	0.116311810208482	0	0	6.130434782608695	18.72965913443862	KDR;VEGFA
KEGG_2021_Human	Calcium signaling pathway	2/240	0.0500581730621325	0.1198362324820749	0	0	5.921968787515006	17.733747043580514	KDR;VEGFA
KEGG_2021_Human	Primary immunodeficiency	1/38	0.0554960388319167	0.1289466784623949	0	0	18.576887232059647	53.71402231134463	CD79A
KEGG_2021_Human	Bladder cancer	1/41	0.0597482042475946	0.1348602324445708	0	0	17.18103448275862	48.409560113017704	VEGFA
KEGG_2021_Human	Malaria	1/50	0.0723939657090184	0.1429780822753113	0	0	14.019000703729768	36.80874147674154	TGFB1
KEGG_2021_Human	Sphingolipid metabolism	1/49	0.070997041562065	0.1429780822753113	0	0	14.311781609195402	37.85633785017516	GLA
KEGG_2021_Human	Vibrio cholerae infection	1/50	0.0723939657090184	0.1429780822753113	0	0	14.019000703729768	36.80874147674154	TCIRG1
KEGG_2021_Human	Glycosphingolipid biosynthesis	1/45	0.0653889820318286	0.1429780822753113	0	0	15.615987460815049	42.59106770539062	GLA
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.0695980839810058	0.1429780822753113	0	0	14.617021276595745	38.95462833164002	TGFB1
KEGG_2021_Human	Endocrine and other factor-regulated calcium reabsorption	1/53	0.0765725660346981	0.1475129485691766	0	0	13.208222811671089	33.938745289872976	AP2B1
KEGG_2021_Human	MicroRNAs in cancer	2/310	0.078424605568423	0.1475129485691766	0	0	4.559833024118738	11.607590991007068	MIR21;VEGFA
KEGG_2021_Human	Glycerolipid metabolism	1/61	0.0876267376582637	0.1609886575582054	0	0	11.442528735632184	27.85877117514337	GLA
KEGG_2021_Human	Inflammatory bowel disease	1/65	0.0931057463211684	0.1671671354402796	0	0	10.72521551724138	25.46186943439083	TGFB1
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	1/70	0.0999097923540907	0.175397191021626	0	0	9.945527236381809	22.909398431433704	TCIRG1
KEGG_2021_Human	Chronic myeloid leukemia	1/76	0.1080095250991305	0.1799761745339458	0	0	9.14712643678161	20.3572579045293	TGFB1
KEGG_2021_Human	Leishmaniasis	1/77	0.1093526123750557	0.1799761745339458	0	0	9.026315789473683	19.976840295907547	TGFB1
KEGG_2021_Human	Thyroid hormone synthesis	1/75	0.1066644800819346	0.1799761745339458	0	0	9.271202236719478	20.749572437350395	ALB
KEGG_2021_Human	B cell receptor signaling pathway	1/81	0.1147054390288231	0.1849332588423883	0	0	8.573275862068966	18.564467269525416	CD79A
KEGG_2021_Human	Complement and coagulation cascades	1/85	0.1200271612483068	0.187977792633311	0	0	8.163382594417078	17.306674925558667	CFHR5
KEGG_2021_Human	Colorectal cancer	1/86	0.1213527522063146	0.187977792633311	0	0	8.066937119675456	17.0136033150249	TGFB1
KEGG_2021_Human	TGF-beta signaling pathway	1/94	0.1318882131320392	0.2003686314890596	0	0	7.370040786058584	14.930232938854378	TGFB1
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.1345029365993388	0.2004855092707126	0	0	7.214156079854809	14.472818068487964	TGFB1
KEGG_2021_Human	Th17 cell differentiation	1/107	0.1487483936763554	0.2173419405793478	0	0	6.461938841899805	12.31321821731818	TGFB1
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1513140092641029	0.2173419405793478	0	0	6.341634738186462	11.975530799282826	VEGFA
KEGG_2021_Human	Oxidative phosphorylation	1/133	0.1815242758910291	0.2390069632565217	0	0	5.182340647857889	8.842969274321403	TCIRG1
KEGG_2021_Human	FoxO signaling pathway	1/131	0.1790469915916031	0.2390069632565217	0	0	5.262599469496021	9.052234105349967	TGFB1
KEGG_2021_Human	Vascular smooth muscle contraction	1/133	0.1815242758910291	0.2390069632565217	0	0	5.182340647857889	8.842969274321403	MYH9
KEGG_2021_Human	Cell cycle	1/124	0.1703192893145684	0.2390069632565217	0	0	5.5640594336977856	9.848832720808518	TGFB1
KEGG_2021_Human	Osteoclast differentiation	1/127	0.1740706605220296	0.2390069632565217	0	0	5.430760810071155	9.494566361812383	TGFB1
KEGG_2021_Human	Gastric cancer	1/149	0.2010840839850956	0.2585999556543538	0	0	4.618359739049394	7.407997409859608	TGFB1
KEGG_2021_Human	Phagosome	1/152	0.2047008959060848	0.2585999556543538	0	0	4.525919159625485	7.179037454618381	TCIRG1
KEGG_2021_Human	Non-alcoholic fatty liver disease	1/155	0.2083018774030301	0.2585999556543538	0	0	4.437080161218092	6.9607445684533715	TGFB1
KEGG_2021_Human	Cellular senescence	1/156	0.2094986982516284	0.2585999556543538	0	0	4.4082313681868746	6.890232053472163	TGFB1
KEGG_2021_Human	Hepatitis B	1/162	0.2166429800184552	0.2607330475592385	0	0	4.242664382094667	6.4891744075022295	TGFB1
KEGG_2021_Human	Hippo signaling pathway	1/163	0.2178276093532878	0.2607330475592385	0	0	4.216262239250745	6.425799996664095	TGFB1
KEGG_2021_Human	Protein processing in endoplasmic reticulum	1/171	0.227242503419016	0.2679426532851084	0	0	4.016227180527383	5.9509945613654756	NFE2L2
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	1/193	0.2525720756457308	0.2934293231766579	0	0	3.5520833333333335	4.88787490008339	VEGFA
KEGG_2021_Human	Pathogenic Escherichia coli infection	1/197	0.2570903983018182	0.2943498763165745	0	0	3.4788881069669246	4.725469425364806	MYH9
KEGG_2021_Human	Lipid and atherosclerosis	1/215	0.2770981851649664	0.3088385314506528	0	0	3.1833709313567513	4.085485334604306	NFE2L2
KEGG_2021_Human	Regulation of actin cytoskeleton	1/218	0.280381770826975	0.3088385314506528	0	0	3.1388844748132847	3.9914153456413297	MYH9
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	1/219	0.2814730919550253	0.3088385314506528	0	0	3.124327744384688	3.960767844335918	TGFB1
KEGG_2021_Human	Human cytomegalovirus infection	1/225	0.2879874992379993	0.3116577046548212	0	0	3.039716748768473	3.783955541889337	VEGFA
KEGG_2021_Human	Coronavirus disease	1/232	0.2955154938047619	0.3154827568996782	0	0	2.9465591879384982	3.5919558655424773	ACE
KEGG_2021_Human	Chemical carcinogenesis	1/239	0.3029665219521898	0.3191247364563065	0	0	2.858881483627934	3.4138846317300957	VEGFA
KEGG_2021_Human	Parkinson disease	1/249	0.3134788398667338	0.324825978646217	0	0	2.742213570634038	3.1810319580645494	NFE2L2
KEGG_2021_Human	Endocytosis	1/252	0.3166025361488444	0.324825978646217	0	0	2.7090259651050967	3.1156727624395613	AP2B1
KEGG_2021_Human	Cytokine-cytokine receptor interaction	1/295	0.3598936550466374	0.364507676265184	0	0	2.3077644851043866	2.358412285668029	TGFB1
KEGG_2021_Human	Huntington disease	1/306	0.3705349586792404	0.3705349586792404	0	0	2.223289994347089	2.2072989439063053	AP2B1
